C4 Therapeutics, Inc.CCCCNASDAQ
Loading
Debt to Assets Over TimeFair Value
Percentile Rank57
3Y CAGR-6.2%
5Y CAGR+23.9%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-6.2%/yr
vs +19.6%/yr prior
5Y CAGR
+23.9%/yr
Recent deceleration
Acceleration
-25.8pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
2.9x
Strong expansion
Streak
3 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.17 | -11.2% |
| 2024 | 0.19 | -0.2% |
| 2023 | 0.19 | -6.8% |
| 2022 | 0.20 | +139.1% |
| 2021 | 0.08 | +47.7% |
| 2020 | 0.06 | -50.7% |
| 2019 | 0.12 | +17.6% |
| 2018 | 0.10 | - |